Analyst firms · Compass Point · CORZ

Compass Point CORZ price target and rating history

Core Scientific Inc. (CORZ) · Finance

Compass Point rates Core Scientific Inc. (CORZ) Buy with a $8.50 price target, as of its latest action on Sep 15, 2025. It has published 3 rating actions on CORZ since September 2022, including 1 upgrade and 0 downgrades. Across 7 firms with a CORZ price target in the last 12 months, the median target is $24.

Current rating
Buy
Price target
$8.50
Median target, all firms
$24
Actions on CORZ
3

Compass Point price target on CORZ

$8.50$4.75$12023202420252026
Compass Point price target on CORZ, each point a stated target, September 2022 to January 2024. Targets before January 2024 (divided by 4) are adjusted for a stock split, going by the prior target Compass Point restated.

Every Compass Point rating on CORZ

How other firms rate CORZ

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
UBSBuy$24Sep 23, 2026
Rothschild & Co RedburnNeutral$16Sep 21, 2026
Wells FargoOverweight$28Sep 17, 2026
Keefe, Bruyette & WoodsOutperform$28Jul 30, 2026
NeedhamBuy$23Mar 3, 2026
BTIGBuy$23Jan 6, 2026
Citizens JMPMkt Outperform$30Dec 18, 2025

Questions about Compass Point and CORZ

What is Compass Point's price target for CORZ?
Compass Point's latest stated price target for Core Scientific Inc. (CORZ) is $8.50, from its action on Jan 31, 2024.
What is Compass Point's rating on CORZ?
Compass Point rates CORZ Buy, a bullish rating, as of Sep 15, 2025.
When did Compass Point last change its view on CORZ?
On Sep 15, 2025, Compass Point resumes coverage at Buy.
How does Compass Point's CORZ target compare with other analysts?
Across 7 firms with a CORZ price target in the last 12 months, the median target is $24.

More CORZ rating histories

All Compass Point ratingsCORZ news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.